News About: Goverment


Safety profile of sibutramine to be independently determined in March, KFDA says

In view of latest studies suggesting higher risk of heart diseases, the Korea’s health watchdog will independently assess the safety profile of sibutramine next month, apart from the decisions in foreign countries. ...

Government urged to boost generic drugs

Generic drugs have long been the competitive edge for local makers, but even they are set to lose steam once the government has expressed a strong will to crack down on pharmaceutical firms offering rebates starting D...

KPMA seeks to integrate anti-rebate provisions

The Korea Pharmaceutical Manufacturers Association is considering incorporating the two different fair trade provisions and self-regulatory pact by the manufacturers to ban the provision of rebates, which have been pr...

State to cover cost-effective drugs

The Health Insurance Review Agency said it has evaluated the effectiveness of existing medicines in order to decide whether they are eligible for the insurance list. The number of medicines to be screened within t...

KFDA reviews generic raw materials of Joins

The Korea Food and Drug Administration has begun to review raw materials and manufacturing process of Joins generics in four manufacturing sites from last week, a source said recently. Joins is an arthritis drug devel...

Medical bill for lung cancer patients goes down

Korea’s National Health Insurance has expanded its coverage to Eli Lilly’s chemotherapy drug Alimta (pemetrexed) as the first line drug for locally advanced or metastatic, nonsquamous, non-small cell lung cancer, acco...

Korean drug price reform imminent

A new wave of price cuts for drugs is speculated to be imminent in Korea, which has stirred up concerns among drug makers, multinational and domestic alike. Rumors have spread that the Ministry of Health and Welfar...

KFDA to issue caution over prescription of weight loss pill sibutramine

Doctors will be advised to restrain the prescription of the controversial anti-obesity drug sibutramine in patients with cardiovascular disease, according to the Korea Food and Drug Administration. The measures com...

Delayed pharmacy school selection triggers suspicion

The Ministry of Education and Human Resources Development will announce a list of candidate universities to open new pharmacy schools as well as its greater enrollment quotas at existing ones in the middle of this Feb...

Congenital heart defects top 45% in new babies with congenital disorders

The incidence of congenital heart disorder (CHD) in Korean babies accounted for 45% of the new births with congenital defects in 2006, a government report said on January 27. According to the report, almost half th...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.